Abagovomab Completed Phase 1 Trials for Primary Peritoneal Cancer / Ovarian Cancer / Fallopian Tube Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0030277 (Primary Peritoneal Cancer) DBCOND0028213 (Ovarian Cancer) DBCOND0028487 (Fallopian Tube Cancer)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00058435	Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer	Abagovomab (DB16077)